Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

OSHA and COVID-19: Workplace Exposures, Citations and Recording

Client Alert

Employer Safety & Health Recommendations, Potential Citations, and Recording Workplace Exposures

The Occupational Safety and Health Administration has issued guidance for protecting employees against workplace exposures to COVID-19.  Employers should also be aware of OSHA standards which may apply to workplace exposures and when a case of COVID-19 is OSHA recordable.

OSHA Guidance
OSHA has issued its Guidance on Preparing Workplaces for COVID-19.  The Guidance sets forth strategies for minimizing workplace exposures.  Note that the Guidance is not an OSHA standard or regulation and does not create new legal obligations on the part of employers.  However, it provides both practical advice for protecting employees and some insight as to when OSHA may issue a General Duty Clause citation in the event of a recordable case of COVID-19 (see Citations below).

OSHA recommends that employers assess the risk level for each job classification, taking into consideration an employee’s contact or close proximity with co-workers, the general public, and those at higher risk for infection, among other factors.  It is recommended that the employer then classify each job according to the following hierarchy:

Lower Exposure Risk (Caution):  Jobs that do not require contact with persons known or suspected to be infected, or frequent close contact (within 6 feet) with the general public.  Most employers will fall into this category.

Medium Exposure Risk:  Jobs that require frequent or close contact with persons who may be infected with the virus but are not known or suspected COVID-19 patients.  This category includes employees having frequent contact with international travelers or working in communities with ongoing COVID-19 transmission.

High Exposure Risk:  Jobs with high potential for exposure to known or suspected sources of COVID-19, such as healthcare workers.

Very High Exposure Risk:  Jobs with high potential for exposure to known or suspected sources of COVID-19 during specific medical, postmortem, or laboratory procedures.

For all employers, OSHA recommends, in order of effectiveness, various engineering controls, administrative controls, and personal protective equipment.  Additional proactive measures are recommended depending upon the risk classification.  Employers should also have contingency plans for workplace outbreaks.

OSHA Standards
Though no OSHA standard specifically covers COVID-19, there are a number of existing standards which may apply to mitigating workplace exposures, as follows:

Personal Protective Equipment:  Applicable PPE standards may include hand, eye, and face protection, as well as respiratory protection.  When respiratory protection is necessary to protect employees, a respiratory protection program must be implemented.  OSHA-mandated workplace hazard assessments should be reviewed and revised as necessary in light of employee exposure risks.

Bloodborne Pathogens:  This standard may apply to occupations where there is reasonably anticipated contact with human blood or “other potentially infectious materials.”  The latter term typically does not include general workplace exposure to others’ respiratory secretions (i.e., co-worker sneezes and coughs), but in such cases, the Bloodborne Pathogen Standard may provide additional guidance to employers for identifying exposure risks and implementing safety measures.

Hazard Communication:  Though perhaps not an ordinary concern for most employers, the Hazard Communication Standard may come into play for employees now using cleaners, sanitizers, or sterilizers for workplace mitigation of COVID-19 exposure.

General Duty Clause:  Section 5(a)(1) of the Occupational Safety and Health Act, better known as the General Duty Clause, requires employers to “furnish to each of his employees employment and a place of employment which are free from recognized hazards that are causing or are likely to cause death or serious physical harm” to its employees.  The General Duty Clause is a catch-all requirement which provides OSHA with enforcement power when no specific safety or health standard applies to a given workplace hazard.

Note that 28 states have a state agency, as opposed to federal OSHA, which enforces workplace safety and health standards.  Most such states adopt the federal OSHA standards in whole (or close to it), but some, such as California, have adopted a broad range of standards unique to the state.  Employers in so-called “state-plan states” should keep abreast of state standards and guidance applicable to COVID-19.

Citations
A workplace injury or illness is not a prerequisite for the issuance of an OSHA citation, as an employer’s violation of any safety or health standard can lead to a citation.  However, as it applies to COVID-19, both an OSHA inspection and citation are unlikely absent extraordinary circumstances, such as an employer’s failure to undertake any precautions to protect against workplace exposures followed by a workplace outbreak of COVID-19.  In such a case, a citation alleging one or more violations of the standards identified above, and the General Duty Clause in particular, is possible.

Recording a COVID-19 Illness
Employers must record work-related illnesses on their OSHA 300 logs.  COVID-19 can be a recordable illness if an employee is infected during the performance of work-related duties.  However, the fact that an employee is diagnosed with COVID-19 and/or first experiences symptoms at work does not make the case recordable.  As with any injury or illness, the case is not recordable unless it is: (i) work-related; (ii) a new case; and (3) results in death, missed or restricted work, job transfer, or medical treatment beyond first aid, or constitutes “a significant injury or illness diagnosed by a physician or other licensed health care professional.”

With the widespread transmission of COVID-19 and the many non-work related avenues for exposure, it is unlikely that an isolated case or two of COVID-19 in a workplace could be fairly characterized as “work-related” (the first of the above three criteria).  Thus, it is unlikely that the employer would have to record the case on its OSHA 300 log.  By contrast, if there is a workplace outbreak among several or more employees who are in close contact with each other, OSHA may consider the cases to be work-related and, therefore, recordable if the second and third criteria are also met.

As a final point, a COVID-19 case is not recordable unless it is a “laboratory-confirmed” case.  The Centers for Disease Control and Prevention (CDC) has developed a classification system for reporting and tracking the virus, as follows:

Person Under Investigation (PUI):  Having sufficient symptoms to cause a healthcare provider to conduct testing.

Presumptive Positive:  At least one respiratory specimen that tested positive for the virus that causes COVID-19 at a state or local laboratory.

Laboratory Confirmed:  At least one respiratory specimen that tested positive for the virus that causes COVID-19 at a CDC laboratory.

If an employer’s case is not a “laboratory-confirmed” case, the employer need not inquire further whether the case is recordable – it is not.

For questions or more information, please contact Stephen Matasich at sematasich@bmdllc.com or 330.253.9146, or any member of the BMD Employment & Labor group.


HHS Provider Relief Funds Reporting Requirements: Important Updates Every Provider Should Know

HHS continues to revise its reporting requirements for the use of the Provider Relief Funds. Providers with more than $10,000 in Provider Relief Fund payments must report on the use of the funds through December 31, 2020. The reporting window will begin on January 15, 2021 and providers must complete reporting obligations for FY 2020 by February 15, 2021 through a portal designed by HHS. However, providers that have unexpended funds as of December 31, 2020, will have an additional 6 months to use the remaining funds through June 30, 2021. These providers must submit a second and final report no later than July 31, 2021.

Should I Apply for Phase 3 Funds? Important Considerations Every Provider Should Know

On October 1, 2020, the Department of Health and Human Services (“HHS”) announced an additional $20 billion in new funding for providers through a Phase 3 distribution. Importantly, providers that previously received HHS Provider Relief Funds or already received payments of approximately 2% of annual revenue from patient care are eligible to apply. Eligible providers have until November 6, 2020 to apply for these Phase 3 Funds. However, the question from providers continues to be: Should I Apply for Phase 3 Funds?

CISA Ransomware Practices

On October 28, 2020, the United States Cybersecurity and Infrastructure Security Agency (CISA) issued an alert warning of imminent threats to US hospitals and healthcare providers. The specific threat involves RYUK Ransomware attacks. RYUK is a novel ransomware that goes undetected by commercial anti-virus/malware detection programs. Once deployed, RYUK encrypts all data and disables systems. In short, it cripples all functionality down to phone systems and automated doors. Healthcare providers should alert their employees to remain hyper-vigilant and report any suspicious activity seen in email or on networks. It has been reported healthcare providers in New York, Pennsylvania and Oregon have been targeted in the last 48 hours. If your organization encounters issues, BMD can assist in mobilizing a response team and has contacts with forensic IT firms that are familiar with RYUK. It is advisable to engage professionals with experience dealing with this specific threat.

HHS Announces an Additional $20 Billion In Provider Relief Grants

The U.S. Department of Health and Human Services (“HHS”) announced an additional $20 billion in new funding for providers on October 1, 2020. Eligible providers include those that have already received Provider Relief Fund payments as well as previously ineligible providers, such as those who began practicing in 2020, and an expanded group of behavioral health providers confronting the emergence of increased mental health and substance use issues exacerbated by the pandemic. The new Phase 3 General Distribution is designed to balance an equitable payment of 2% of annual revenue from patient care for all applicants plus an add-on payment to account for revenue losses and expenses attributable to COVID-19.

DOL Proposes New Rule Regarding Independent Contractor Status - But How Will the Election Affect Its Future?

On September 22, 2020, the U.S. Department of Labor announced a new proposed rule regarding employee and independent contractor status under the Fair Labor Standards Act. The full text of the proposed rule is available here. The rule's drafters intend to reduce uncertainty and enhance the precision and predictability of the long-standing "economic reality" test, which currently relies on a multifactor balancing test.